View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
This product is sold strictly for laboratory research purposes only
Without sufficient oxygen being delivered from red blood cells, your muscles will feel weak
BPC-157 vs TB-500 Research Peptide Comparison BPC-157 vs TB-500 Key Differences in Research BPC-157 and TB-500 are two of the most widely studied peptides in laboratory research involving tissue repair, cellular signalling, and regenerative processes
BPC 157 was added into each well at the concentration of 0 (control group), 0.1, 0.25 and 0.5 g/mL for 1, 2, and 3 days at 37 C in a humidified atmosphere of 5% CO 2 /95% air